| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ana Claudia R Durante, Danielle V Sobral, Ana Claudia C Miranda, Érika V de Almeida, Leonardo L Fuscaldi, Marycel R F F de Barboza, Luciana Malavolt. Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen Pharmaceuticals (Basel, Switzerland). vol 12. issue 1. 2020-09-30. PMID:30764521. |
comparative study of two oxidizing agents, chloramine t and iodo-gen parkinson's disease (pd) is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the |
2020-09-30 |
2023-08-13 |
Not clear |
| Seok Jong Chung, Jae Jung Lee, Phil Hyu Lee, Young H Soh. Emerging Concepts of Motor Reserve in Parkinson's Disease. Journal of movement disorders. vol 13. issue 3. 2020-09-30. PMID:32854486. |
parkinson's disease (pd) is also a common neurodegenerative disease and is mainly characterized by motor dysfunction related to striatal dopaminergic depletion. |
2020-09-30 |
2023-08-13 |
Not clear |
| Shane V Hegarty, Aideen M Sullivan, Gerard W O'Keeff. Protocol for evaluation of neurotrophic strategies in Parkinson's disease-related dopaminergic and sympathetic neurons Journal of biological methods. vol 3. issue 3. 2020-09-29. PMID:31453215. |
protocol for evaluation of neurotrophic strategies in parkinson's disease-related dopaminergic and sympathetic neurons parkinson's disease (pd) is a neurodegenerative disease that is characterized by motor and non-motor symptoms which result from the progressive degeneration of nigrostriatal ventral midbrain (vm) dopaminergic (da) neurons, as well as peripheral sympathetic neurons. |
2020-09-29 |
2023-08-13 |
Not clear |
| Minjing Ke, Cheong-Meng Chong, Huanxing S. Using induced pluripotent stem cells for modeling Parkinson's disease. World journal of stem cells. vol 11. issue 9. 2020-09-28. PMID:31616540. |
parkinson's disease (pd) is an age-related neurodegenerative disease caused by the progressive loss of dopaminergic (da) neurons in the substantia nigra. |
2020-09-28 |
2023-08-13 |
human |
| Yun-Cheng Lv, An-Bo Gao, Jing Yang, Li-Yuan Zhong, Bo Jia, Shu-Hui Ouyang, Le Gui, Tian-Hong Peng, Sha Sun, Francisco S Cayabya. Long-term adenosine A1 receptor activation-induced sortilin expression promotes α-synuclein upregulation in dopaminergic neurons. Neural regeneration research. vol 15. issue 4. 2020-09-28. PMID:31638096. |
prolonged activation of adenosine a1 receptor likely leads to damage of dopaminergic neurons and subsequent development of neurodegenerative diseases. |
2020-09-28 |
2023-08-13 |
rat |
| Yuyang Sun, Amrita Kamat, Brij B Sing. Isoproterenol-Dependent Activation of TRPM7 Protects Against Neurotoxin-Induced Loss of Neuroblastoma Cells. Frontiers in physiology. vol 11. 2020-09-28. PMID:32390858. |
loss of ion channel function is known to induce neurodegenerative diseases such as parkinson's that exhibit loss of dopaminergic neurons; however, mechanisms that could limit neuronal loss are not yet fully identified. |
2020-09-28 |
2023-08-13 |
Not clear |
| Sabyasachi Chakraborty, Satyabrata Aich, Hee-Cheol Ki. Detection of Parkinson's Disease from 3T T1 Weighted MRI Scans Using 3D Convolutional Neural Network. Diagnostics (Basel, Switzerland). vol 10. issue 6. 2020-09-28. PMID:32545609. |
parkinson's disease is a neurodegenerative disease that affects the aging population and is caused by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta (snc). |
2020-09-28 |
2023-08-13 |
human |
| Jana Harsanyiova, Tomas Buday, Alzbeta Kralova Trancikov. Parkinson's Disease and the Gut: Future Perspectives for Early Diagnosis. Frontiers in neuroscience. vol 14. 2020-09-28. PMID:32625058. |
parkinson's disease (pd) is a neurodegenerative disease characterized by progressive degeneration of dopaminergic neurons, and at the cellular level by the formation of lewy bodies in the central nervous system (cns). |
2020-09-28 |
2023-08-13 |
Not clear |
| Gerard W O'Keeffe, Shane V Hegarty, Aideen M Sulliva. Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease. Neuronal signaling. vol 1. issue 2. 2020-09-28. PMID:32714578. |
parkinson's disease (pd) is the second most common neurodegenerative disease, characterized by the degeneration of midbrain dopaminergic (mda) neurons and their axons, and aggregation of α-synuclein, which leads to motor and late-stage cognitive impairments. |
2020-09-28 |
2023-08-13 |
Not clear |
| Shane V Hegarty, Aideen M Sullivan, Gerard W O'Keeff. Inhibition of Neuronal signaling. vol 2. issue 1. 2020-09-28. PMID:32714583. |
inhibition of parkinson's disease (pd) is the second most common neurodegenerative disease, and is characterized by the progressive degeneration of nigrostriatal dopaminergic (da) neurons. |
2020-09-28 |
2023-08-13 |
Not clear |
| Yanjun Huang, Lirong Sun, Shuzhen Zhu, Liu Xu, Shuhu Liu, Chunhua Yuan, Yanwu Guo, Xuemin Wan. Neuroprotection Against Parkinson's Disease Through the Activation of Akt/GSK3β Signaling Pathway by Tovophyllin A. Frontiers in neuroscience. vol 14. 2020-09-28. PMID:32742256. |
neuroprotection against parkinson's disease through the activation of akt/gsk3β signaling pathway by tovophyllin a. parkinson's disease (pd) is one of the most prevalent and life-threatening neurodegenerative disease and mainly characterized by lack of sufficient dopaminergic neurons in the substantia nigra pars compacta (snc). |
2020-09-28 |
2023-08-13 |
Not clear |
| Chih-Hsin Lin, Pei-Cih Wei, Chiung-Mei Chen, Yu-Ting Huang, Jia-Lan Lin, Yen-Shi Lo, Jia-Li Lin, Chung-Yin Lin, Yih-Ru Wu, Kuo-Hsuan Chang, Guey-Jen Lee-Che. Lactulose and Melibiose Attenuate MPTP-Induced Parkinson's Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy. Frontiers in aging neuroscience. vol 12. 2020-09-28. PMID:32848705. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by the progressive loss of dopaminergic (daergic) neurons in the ventral brain. |
2020-09-28 |
2023-08-13 |
mouse |
| Khalid I W Kane, Edinson Lucumi Moreno, Siham Hachi, Moriz Walter, Javier Jarazo, Miguel A P Oliveira, Thomas Hankemeier, Paul Vulto, Jens C Schwamborn, Martin Thoma, Ronan M T Flemin. Automated microfluidic cell culture of stem cell derived dopaminergic neurons. Scientific reports. vol 9. issue 1. 2020-09-21. PMID:30741972. |
parkinson's disease is a slowly progressive neurodegenerative disease characterised by dysfunction and death of selectively vulnerable midbrain dopaminergic neurons and the development of human in vitro cellular models of the disease is a major challenge in parkinson's disease research. |
2020-09-21 |
2023-08-13 |
human |
| Wafaa Laabbar, Abdeljalil Elgot, Omar Elhiba, Halima Gamran. Curcumin prevents the midbrain dopaminergic innervations and locomotor performance deficiencies resulting from chronic aluminum exposure in rat. Journal of chemical neuroanatomy. vol 100. 2020-09-11. PMID:31170442. |
though its influence is evidently shown in the substantia nigra of parkinson's disease patients and other brain areas in other neurodegenerative diseases, few studies have demonstrated that al could trigger profound changes in neurotransmission systems including the dopaminergic (daergic) system. |
2020-09-11 |
2023-08-13 |
rat |
| Jun Takahash. Preclinical evaluation of patient-derived cells shows promise for Parkinson's disease. The Journal of clinical investigation. vol 130. issue 2. 2020-09-04. PMID:31929191. |
parkinson's disease (pd) is a neurodegenerative disease caused by the progressive loss of dopaminergic (da) neurons in the midbrain projecting to the striatum, which leads to motor dysfunctions, such as bradykinesia (slowed movement), rigidity, and tremors. |
2020-09-04 |
2023-08-13 |
Not clear |
| Zhan Liu, Ao-Wang Qiu, Yan Huang, Ya Yang, Jin-Na Chen, Ting-Ting Gu, Bei-Bei Cao, Yi-Hua Qiu, Yu-Ping Pen. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease. Brain, behavior, and immunity. vol 81. 2020-08-14. PMID:31351185. |
neuroinflammation has been involved in pathogenesis of parkinson's disease (pd), a chronic neurodegenerative disease characterized neuropathologically by progressive dopaminergic neuronal loss in the substantia nigra (sn). |
2020-08-14 |
2023-08-13 |
mouse |
| Zhong Feng, Li Zhang, Sa Wang, Qing Hon. Circular RNA circDLGAP4 exerts neuroprotective effects via modulating miR-134-5p/CREB pathway in Parkinson's disease. Biochemical and biophysical research communications. vol 522. issue 2. 2020-08-12. PMID:31761328. |
parkinson's disease (pd) is a neurodegenerative disease which is characterized by the substantia nigra dopaminergic neurons denatured. |
2020-08-12 |
2023-08-13 |
mouse |
| Rita Marreiros, Andreas Müller-Schiffmann, Svenja V Trossbach, Ingrid Prikulis, Sebastian Hänsch, Stefanie Weidtkamp-Peters, Ana Raquel Moreira, Shriya Sahu, Irina Soloviev, Suganya Selvarajah, Vishwanath R Lingappa, Carsten Kort. Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation. Proceedings of the National Academy of Sciences of the United States of America. vol 117. issue 12. 2020-07-07. PMID:32152117. |
here, we investigated the effect of influenza virus (h1n1) strains on proteostasis of proteins associated with neurodegenerative diseases in lund human mesencephalic dopaminergic cells in vitro and infection of |
2020-07-07 |
2023-08-13 |
human |
| Sabine Morris Hey, Pia Jensen, Matias Ryding, Alberto Martínez Serrano, Bjarne W Kristensen, Morten Meye. Nonhypoxic pharmacological stabilization of Hypoxia Inducible Factor 1α: Effects on dopaminergic differentiation of human neural stem cells. The European journal of neuroscience. vol 49. issue 4. 2020-06-22. PMID:30471165. |
parkinson's disease is a neurodegenerative disease resulting in degeneration of midbrain dopaminergic neurons. |
2020-06-22 |
2023-08-13 |
human |
| Ardeshir Moayeri, Marzieh Darvishi, Mansour Amrae. Homing of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) Labeled Adipose-Derived Stem Cells by Magnetic Attraction in a Rat Model of Parkinson's Disease. International journal of nanomedicine. vol 15. 2020-06-19. PMID:32161459. |
stem cell therapies for neurodegenerative diseases such as parkinson's disease (pd) are intended to replace lost dopaminergic neurons. |
2020-06-19 |
2023-08-13 |
rat |